Etbicyphat (CAS 1005-93-2)

Etbicyphat, a synthetic compound, exhibits non-competitive antagonism towards GABA receptors, potentially inhibiting both GABA-gated and voltage-dependent Cl- channels. It has also demonstrated the ability to inhibit the binding of dihydropicrotoxin and t-butylbicyclo-phosphorothionate. Derived from trimethylolpropane (TMP), Etbicyphat is widely utilized in various industrial and scientific applications. Primarily, Etbicyphat serves as a versatile chemical in industrial settings. It finds applications as a cross-linking agent, plasticizer, and emulsifier. Furthermore, it plays a role in the production of polyurethane foams, adhesives, coatings, and elastomers. In biomedical research, Etbicyphat has been extensively investigated for its potential bioactivity. Studies have explored its impact on protein structure and function, examining the effects of phosphorylation and its involvement in signal transduction pathways. The compound has also been investigated for its influence on enzyme activity regulation and gene expression control through phosphorylation. Believed to act as a phosphorylation agent, Etbicyphat is thought to interact with specific enzymes, such as protein kinases and phosphatases, modulating their activity. These enzymes play vital roles in regulating various cellular processes. Overall, Etbicyphat presents itself as a valuable compound in both industrial and biomedical realms. Its wide range of applications contributes to industrial processes while offering insights into protein dynamics, phosphorylation-mediated signaling, and enzymatic regulation.